Cite
HARVARD Citation
Goll, R. et al. (n.d.). P314 TNF gene activation used as criterion to discontinue biologic therapy – A patient series introducing the NovaPrime TNF kit. Journal of Crohn's and colitis. pp. S340-S341. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Goll, R. et al. (n.d.). P314 TNF gene activation used as criterion to discontinue biologic therapy – A patient series introducing the NovaPrime TNF kit. Journal of Crohn's and colitis. pp. S340-S341. [Online].